CN Patent

CN102281869A — 替诺福韦、恩曲他滨和依法韦仑的湿法制粒

Assigned to ULTIMORPHIX TECHNOLOGIES BV · Expires 2011-12-14 · 14y expired

What this patent protects

本发明描述了基于替诺福韦酯半富马酸盐、恩曲他滨和依法韦仑的药物产品的方法和组合物。所述组合物可通过包括湿法制粒步骤的方法来制备以生产适用于治疗HIV的稳定的基本上无已知降解产物的剂型。

USPTO Abstract

本发明描述了基于替诺福韦酯半富马酸盐、恩曲他滨和依法韦仑的药物产品的方法和组合物。所述组合物可通过包括湿法制粒步骤的方法来制备以生产适用于治疗HIV的稳定的基本上无已知降解产物的剂型。

Drugs covered by this patent

Patent Metadata

Patent number
CN102281869A
Jurisdiction
CN
Classification
—
Expires
2011-12-14
Drug substance claim
No
Drug product claim
No
Assignee
ULTIMORPHIX TECHNOLOGIES BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.